Chimeric antigen receptor T cells can eradicate large burdens of multiple myeloma, according to a new study presented at ASH.
Mark L. Fuerst
Advertisement
Articles by Mark L. Fuerst
Advertisement
Latest Updated Articles
- Engineered CAR T Cells Show Promise in Multiple Myeloma
Published: December 7th 2015 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
CGTLive®’s Weekly Rewind – October 24, 2025
2
Guess the Therapy Answer October 23, 2025
3
CARsgen’s CAR-T Satri-Cel Significantly Reduces CA19-9 Levels in Patients With Pancreatic Ductal Adenocarcinoma
4
